Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours-Reference-Cited by-同舟云学术

Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours

Published:2002-12 Issue:7 Volume:43 Page:1110-1118
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Finberg John P.M.,Youdim Moussa B.H.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference43 articles.

1. Behavioural response to combined treatment with inhibitors of MAO and the selective inhibitor of 5-HT uptake, LM 5008;Ashkenazi;British Journal of Pharmacology,1983

2. The potentiation of anti-akinetic effect after L-dopa treatment by an inhibitor of MAO-B, deprenyl;Birkmayer;Journal of Neural Transmission,1975

3. Implications of combined treatment with Madopar and l-deprenyl in Parkinson’s disease;Birkmayer;Lancet,1977

4. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in rat brain;Campbell;Journal of Neurochemistry,1979

5. Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson’s disease;Churchyard;Journal of Neurology, Neurosurgery and Psychiatry,1997

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring in Parkinson’s disease;Journal of Neural Transmission;2024-09-03

2. Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity;European Journal of Medicinal Chemistry;2024-04

3. The effect of rasagiline on swallowing function in Parkinson's disease;Heliyon;2024-01

4. L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin;Journal of Neural Transmission;2023-10-05

5. Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies;International Journal of Molecular Sciences;2022-09-21